Sanara MedTech (SMTI) Change in Accured Expenses (2016 - 2024)
Sanara MedTech's Change in Accured Expenses history spans 14 years, with the latest figure at -$783390.0 for Q1 2024.
- For Q1 2024, Change in Accured Expenses rose 59.81% year-over-year to -$783390.0; the TTM value through Mar 2024 reached $1.1 million, down 25.46%, while the annual FY2023 figure was -$81513.0, 102.72% down from the prior year.
- Change in Accured Expenses reached -$783390.0 in Q1 2024 per SMTI's latest filing, down from $1.6 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $1.6 million in Q4 2023 to a low of -$1.9 million in Q1 2023.
- Average Change in Accured Expenses over 5 years is $231970.4, with a median of $225008.0 recorded in 2021.
- Peak YoY movement for Change in Accured Expenses: plummeted 380.24% in 2020, then soared 693.02% in 2021.
- A 5-year view of Change in Accured Expenses shows it stood at $888265.0 in 2020, then tumbled by 48.39% to $458405.0 in 2021, then soared by 222.35% to $1.5 million in 2022, then increased by 7.75% to $1.6 million in 2023, then crashed by 149.2% to -$783390.0 in 2024.
- Per Business Quant, the three most recent readings for SMTI's Change in Accured Expenses are -$783390.0 (Q1 2024), $1.6 million (Q4 2023), and $185400.0 (Q3 2023).